Страна: Великобритания
Език: английски
Източник: VMD (Veterinary Medicines Directorate)
Clostridium chauvoei, Clostridium novyi, Clostridium perfringens, Clostridium septicum, Clostridium tetani
Intervet UK Ltd
SheepQI0
Clostridium chauvoei, Clostridium novyi, Clostridium perfringens, Clostridium septicum, Clostridium tetani
Expired
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Heptavac 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE(S): PER ML _Clostridum perfringens_ type B 30-60 TCP units _Clostridum perfringens_ type C 30-60 TCP units _Clostridium perfringens_ type D 80-160 TCP units _Clostridium septicum_ 3-6 TCP units _Clostridium tetani_ 6-12 TCP units _Clostridium novyi_ 8-16 TCP units _Clostridum chauvoei,_ strain 655 1.25 x 10 8 cells and equivalent toxoid _Clostridum chauvoei,_ strain 656 1.25 x 10 8 cells and equivalent toxoid_ _ _Clostridum chauvoei,_ strain 657 1.25 x 10 8 cells and equivalent toxoid_ _ _Clostridum chauvoei,_ strain 658 1.25 x 10 8 cells and equivalent toxoid_ _ _Clostridum chauvoei,_ strain 1048 1.25 x 10 8 cells and equivalent toxoid ADJUVANT(S): Aluminium hydroxide gel, 375 mg/ml EXCIPIENTS: Thiomersal, 0.13 mg/ml Formaldehyde, <0.2 mg/ml 3. PHARMACEUTICAL FORM Suspension for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep and pigs. 4.2 INDICATIONS FOR USE SPECIFYING THE TARGET SPECIES (IF APPROPRIATE) Sheep_ _ For the active immunisation of sheep not less than 3 weeks old to: - reduce clinical signs and mortality due to the toxin of _Clostridium tetani _(Tetanus); - reduce mortality due to the epsilon toxin of _Clostridium perfringens (_Pulpy kidney) - reduce mortality due to the toxin of _Clostridium novyi_ (Black disease); - reduce mortality in sheep due to infections with _Clostridium chauvoei_ (Blackleg); - induce a serological response against the beta toxin of _Clostridium perfringens_ (Struck, Lamb dysentery); - induce a serological response against the toxin of _Clostridium septicum_ (Braxy). Significant levels of immunity cannot be expected until two weeks after the second dose of vaccine in the primary vaccination co Прочетете целия документ